Invega Sustenna Vial 100 mg
-
Regular price
-
1,213.50 SR
-
Sale price
-
1,213.50 SR
-
Regular price
-
-
Unit price
-
/
per
Description
Invega Sustenna Vial 100 mg
Description: Invega Sustenna is an antipsychotic medication used for the treatment of schizophrenia and schizoaffective disorder. The active ingredient, paliperidone, is an atypical antipsychotic that helps to balance chemicals in the brain, improving symptoms such as hallucinations, delusions, and disorganized thinking. It is administered as an intramuscular injection and provides long-lasting relief from symptoms.
Ingredients:
- Active Ingredient:
- Inactive Ingredients:
- Polylactide-co-glycolide (PLGA)
- Sodium chloride
- Water for injection
Usage Instructions:
- Administered as an intramuscular injection, typically in the deltoid or gluteal muscle.
- Dosage is usually given once monthly, with initial doses often higher to achieve therapeutic levels.
- Follow your healthcare provider’s instructions for the exact dosing schedule and site of injection.
- Injection should be given by a healthcare professional.
Benefits:
- Effective management of symptoms associated with schizophrenia and schizoaffective disorder.
- Provides stable, long-term control with once-monthly dosing, reducing the need for daily medication.
- Can improve overall quality of life by helping to manage psychotic symptoms and improve functioning.
Precautions:
- Not suitable for individuals with known hypersensitivity to paliperidone or risperidone.
- Use with caution in patients with a history of cardiovascular disease, seizures, or diabetes.
- Possible side effects include weight gain, drowsiness, dizziness, and potential for extrapyramidal symptoms (e.g., tremors, stiffness).
- Regular monitoring is recommended for potential side effects and therapeutic effectiveness.
Storage Instructions:
- Store in a refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze.
- Protect from light and keep the vial in the original carton until use.
- Keep out of reach of children.
Manufacturer: Janssen Pharmaceutica NV.